ACAT inhibitors (Schering-Plough)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameACAT inhibitors (Schering-Plough)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase
Therapy Area/IndicationsHypercholesterolemiaAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough Corp
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A